Meeting
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
Authors
Ahmed M. Mahmoud
Mayo Clinic Rochester, Rochester, MN
Ahmed M. Mahmoud , Patrick Navin , Miguel Muniz , Fernando Quevedo , Jacob Orme , Jack R. Andrews , Adam McLain Kase , Osama M Mosalem , Alan Haruo Bryce , Irbaz Bin Riaz , Brian J. Burkett , Ayse T. Kendi , Geoffrey Johnson , Praful Ravi , Eugene D. Kwon , Oliver Sartor , Daniel S Childs
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 49)
DOI
10.1200/JCO.2024.42.4_suppl.49
Abstract #
49
Poster Bd #
B6
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
SABRE: Assessment of safety and efficacy of 64Cu-SAR-BBN in patients with PSMA-negative biochemical recurrent prostate cancer.
First Author: Luke T. Nordquist
Poster
2023 ASCO Annual Meeting
Prostate-specific membrane antigen ligand positron emission tomography (PSMA-PET) disease extent and overall survival (OS) in patients (pts) with high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC): An international multicenter retrospective study.
First Author: Boris A. Hadaschik
Poster
2023 ASCO Annual Meeting
Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.
First Author: Alberto Carretero-González
Poster
2017 Genitourinary Cancers Symposium
The CHAPPP study: Changing care with PSMA-PET for Prostate cancer—A retrospective study of the role of PSMA imaging in altering treatment pathways.
First Author: Andrew Schmidt